Northern Trust’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85,222
| Closed | -$70.3K | – | 4453 |
|
|
2025
Q1 | $70.3K | Buy |
85,222
+10,875
| +15% | +$10.5K | ﹤0.01% | 4176 |
|
|
2024
Q4 | $70.6K | Hold |
74,347
| – | – | ﹤0.01% | 4215 |
|
|
2024
Q3 | $74.3K | Sell |
74,347
-1,220
| -2% | -$1.35K | ﹤0.01% | 4127 |
|
|
2024
Q2 | $93.7K | Sell |
75,567
-60
| -0.1% | -$61 | ﹤0.01% | 4069 |
|
|
2024
Q1 | $98.3K | Sell |
75,627
-17,046
| -18% | -$19.4K | ﹤0.01% | 4085 |
|
|
2023
Q4 | $116K | Hold |
92,673
| – | – | ﹤0.01% | 4078 |
|
|
2023
Q3 | $120K | Sell |
92,673
-947
| -1% | -$1.53K | ﹤0.01% | 3963 |
|
|
2023
Q2 | $161K | Sell |
93,620
-257,046
| -73% | -$408K | ﹤0.01% | 3900 |
|
|
2023
Q1 | $512K | Buy |
350,666
+3,285
| +0.9% | +$6.3K | ﹤0.01% | 3465 |
|
|
2022
Q4 | $563K | Sell |
347,381
-6,479
| -2% | -$14.9K | ﹤0.01% | 3458 |
|
|
2022
Q3 | $1.19M | Sell |
353,860
-1,980
| -0.6% | -$8.94K | ﹤0.01% | 3256 |
|
|
2022
Q2 | $1.3M | Sell |
355,840
-3,340
| -0.9% | -$15.1K | ﹤0.01% | 3268 |
|
|
2022
Q1 | $2.6M | Sell |
359,180
-19,358
| -5% | -$165K | ﹤0.01% | 2960 |
|
|
2021
Q4 | $5.14M | Buy |
378,538
+26,156
| +7% | +$409K | ﹤0.01% | 2664 |
|
|
2021
Q3 | $7.39M | Buy |
352,382
+26,813
| +8% | +$576K | ﹤0.01% | 2491 |
|
|
2021
Q2 | $7.8M | Buy |
325,569
+163,311
| +101% | +$4.13M | ﹤0.01% | 2545 |
|
|
2021
Q1 | $4.75M | Sell |
162,258
-7,569
| -4% | -$222K | ﹤0.01% | 2780 |
|
|
2020
Q4 | $5.07M | Buy |
+169,827
| New | +$5.33M | ﹤0.01% | 2678 |
|
Northern Trust's KRON Position: Q2 2025 in Review
Northern Trust sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 85,222 shares — an estimated $70.3K sold.
Northern Trust first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $7.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Northern Trust reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Northern Trust sold 85,222 Kronos Bio shares in Q2 2025, an estimated $70.3K.
- Northern Trust first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
- Northern Trust's Kronos Bio position peaked at $7.8M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.